Newsletter Subject

Ocaliva for NASH Gets Thumbs Down From FDA Advisors

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, May 19, 2023 10:52 PM

Email Preheader Text

Daily Headlines Friday, May 19, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT THE

[MEDPAGE TODAY]( Daily Headlines Friday, May 19, 2023 Today's Top Stories for {NAME} [GASTROENTEROLOGY]( [Ocaliva for NASH Gets Thumbs Down From FDA Advisors]( [PRIMARY CARE]( [How Can Primary Care Be Improved in the U.S.?]( [DERMATOLOGY]( [Rare Skin Blistering Condition Gets First Drug Approved]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [COVID-19 Prevention for Immunocompromised Individuals]( [MEETING COVERAGE]( [PCI 'Roadmap' for the Coronary Tree Cuts Contrast Use]( [ONCOLOGY/HEMATOLOGY]( [Skipping Meds for Cost; Colonoscopy Prior Auth Jitters; VTE Prevention Update]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [ONCOLOGY/HEMATOLOGY]( [Bispecific Antibody Approved for Relapsed/Refractory Diffuse Large B-Cell Lymphoma]( CME SPOTLIGHT [Applying Evidence-Based Clinical Decision-Making to Real-world Patient Cases to Support Safe, Effective, and Adherent Treatment in TNBC]( [OPHTHALMOLOGY]( [Study Throws Shade on Cost, Benefits of Laser-Assisted Cataract Surgery]( [INFECTIOUS DISEASE]( [Health Professionals React to the End of the COVID Public Health Emergency]( [ONCOLOGY/HEMATOLOGY]( [ADC Plus Low-Intensity Chemo Promising in Older Patients With B-Cell ALL]( CME SPOTLIGHT [Navigating PNH Recognition, Diagnosis, and Treatment]( [ENDOCRINOLOGY]( [FDA Clears iLet Bionic Pancreas System for Type 1 Diabetes]( [MEETING COVERAGE]( [TAVR Valves Fail Fast in ESRD, Study Shows]( [SPECIAL REPORTS]( [FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs]( CME SPOTLIGHT [Guideline Recommendations for Treatment Selection and Sequencing in Relapsed/Refractory Multiple Myeloma]( [OB/GYN]( [Abortion Pill Case Returns to Fifth Circuit Court of Appeals]( [MEETING COVERAGE]( [Door Shut on Excess Noncardiac Deaths After Intervention for Stable CAD]( [MEETING COVERAGE]( [Withdrawal of Care Common in STEMI, but Palliative Care Is Not]( CME SPOTLIGHT [Novel Mechanisms and Therapeutic Targets in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [HF Shunt Results Hold Up Midterm in Early Data]( [SPECIAL REPORTS]( [Lumpers vs Splitters: Categorizing Prostate Cancer]( [PEDIATRICS]( [High-dose Vitamin D3 May Be Protective Against Some Childhood Behavioral Problems]( CME SPOTLIGHT [Advancing AML Care: A Targeted Approach]( [AAD READING ROOM]( [JAK Inhibitors Bring Fast Itch Relief]( [MEETING COVERAGE]( [Bioresorbable Scaffold Concept Evolves Into 'Revolutionary' Hybrid]( [ASCO READING ROOM]( [FLIM for FRET: Assessing the PD1/PD-L1 Functional Complex in NSCLC]( # Weekly Survey [Prescribe Weight Loss Drugs Based on BMI Alone?]( GLP-1 agonists have been approved for obesity based on their BMI, but [some argue]( BMI isn't a good measure of health[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-05-19&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.